DocGo (NASDAQ:DCGO – Get Free Report) and Gaxos.ai (NASDAQ:GXAI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.
Earnings & Valuation
This table compares DocGo and Gaxos.ai”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.12 | -$182.40 million | ($1.96) | -0.19 |
| Gaxos.ai | $1.93 million | 2.39 | -$3.90 million | ($0.50) | -1.30 |
Volatility & Risk
DocGo has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500. Comparatively, Gaxos.ai has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
Institutional & Insider Ownership
56.4% of DocGo shares are owned by institutional investors. Comparatively, 42.6% of Gaxos.ai shares are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 3.2% of Gaxos.ai shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares DocGo and Gaxos.ai’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -65.29% | -40.42% | -24.81% |
| Gaxos.ai | -64.81% | -38.79% | -36.99% |
Analyst Ratings
This is a breakdown of current ratings and price targets for DocGo and Gaxos.ai, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 2 | 3 | 0 | 2.33 |
| Gaxos.ai | 1 | 0 | 0 | 0 | 1.00 |
DocGo currently has a consensus target price of $2.38, indicating a potential upside of 533.00%. Given DocGo’s stronger consensus rating and higher possible upside, research analysts clearly believe DocGo is more favorable than Gaxos.ai.
Summary
DocGo beats Gaxos.ai on 8 of the 14 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About Gaxos.ai
Gaxos.ai Inc. engages in developing artificial intelligence applications for various sectors. Its portfolio includes applications in mental and physical wellbeing, coaching, and gaming. In addition, it offers Gaxos, a gaming platform develop, design, acquire, and manage conventional games and combine these games with unconventional game mechanisms. The company was formerly known as The NFT Gaming Company, Inc. and changed its name to Gaxos.ai Inc. in January 2024. Gaxos.ai Inc. was incorporated in 2021 and is based in Roseland, New Jersey.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
